Health groups ask India to rescind Gilead's patents for COVID-19 drug remdesivir

Two health advocacy groups have written to the Indian government asking it to rescind patents given to Gilead Sciences for the drug remdesivir so it can be distributed more fairly to coronavirus patients around the world, particularly in poorer nations.